Cite
MLA Citation
A. Nayak et al.. “346 Phase 1a study of the safety, pharmacokinetics, and pharmacodynamics of GDC-0919 in patients with recurrent/advanced solid tumors.” European journal of cancer, vol. 51, n.d., pp. S69–. http://access.bl.uk/ark:/81055/vdc_100030627995.0x00002d